Moreover, CCL5 is identified as the dominant chemokine (in an inducible nitric oxide synthase-dependent but not NF-kappa B-dependent fashion) expressed in vivo in the islet inflammatory microenvironment of prediabetic animals and T1DM patients (78). This evidence concerns the gene CCL5 and type 1 diabetes mellitus.